• Connect with us
  • Information
    • About Us
    • Contact Us
    • Careers
    • Partnerships
    • Advertise With Us
    • Authors
    • Browse Topics
    • Events
    • Disclaimer
    • Privacy Policy
  • NORTH AMERICA EDITION
    Australia
    North America
    World
Login
Investing News NetworkYour trusted source for investing success
  • NORTH AMERICA EDITION
    North America
    Australia
    World
  • My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
  • Reports & Guides
    • Market Outlook Reports
    • Investing Guides
  • Button
Resource
  • Precious Metals
  • Battery Metals
  • Base Metals
  • Energy
  • Critical Minerals
Tech
Life Science
Life Science Market
Life Science News
Life Science Stocks
  • Life Science Market
  • Life Science News
  • Life Science Stocks
life science investing

Antidepressants Linked to Lower Heart Disease

Charlotte McLeod
Mar. 09, 2015 04:13PM PST
Life Science Investing

According to a Science World Report article, a new study indicates that patients treated with antidepressants have lower lower mortality rates, as well as lower stroke and artery disease when compared to patients not treated with such medication.

According to a Science World Report article, a new study indicates that patients treated with antidepressants have lower lower mortality rates, as well as lower stroke and artery disease when compared to patients not treated with such medication.

As quoted in the market news:

The study, based on three years of research, involved about 5,311 people who were affected by severe depression out of over 26,000 patients who were treated at the involved medical facility. The results showed that 20 percent had moderate or severe depression while the remaining 21,517 patients didn’t show depression based on a 9-question depression screen.

Heidi May, the lead author of the study and a public health scientist, commented:

This study demonstrates the importance of evaluating patients for depression,not only in terms of improving their mood, but reducing their risk for heartdisease.

Antidepressants were not associated with a reduced cardiovascular risk in people with little or no depression, but in moderately to severely depressed people, antidepressants were shown to significantly improve cardiovascular outcomes. We thought we’d see an additive effect.

Click here to read the full Science World Report article.

life science investing
The Conversation (0)

Go Deeper

AI Powered
Albert Labs

Albert Labs

FDA approval of CAPLYTA®  has the potential to reset treatment expectations, offering hope for remission in adults with major depressive disorder

FDA approval of CAPLYTA® has the potential to reset treatment expectations, offering hope for remission in adults with major depressive disorder

Latest News

Lobe Sciences Reports FY2025 with a Stronger Balance Sheet and Sharpened Strategy

U.S. Patent allowance received for PTSD discovery programme

Seegnal's operating subsidiary Seegnal E-Health Ltd. hires AI VP to Strengthen AI Capabilities and Accelerates Development of Seegnal Guard

Lobe Sciences Reports Fiscal 2025 Results and Highlights Strategic Transformation Following Leadership Transition

More News

Outlook Reports

Resource
  • Precious Metals
    • Gold
    • Silver
  • Battery Metals
    • Lithium
    • Cobalt
    • Graphite
    • Electric Vehicles
  • Agriculture
  • Base Metals
    • Copper
    • Nickel
    • Zinc
  • Critical Metals
    • Rare Earths
  • Energy
    • Uranium
    • Oil and Gas
Tech
    • Artificial Intelligence
    • Cybersecurity
    • Robotics
    • Crypto
    • Cleantech
Life Science
    • Biotech
    • Cannabis
    • Pharmaceuticals

Featured Life Science Investing Stocks

More featured stocks

Browse Companies

Resource
  • Precious Metals
  • Battery Metals
  • Energy
  • Base Metals
  • Critical Metals
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES